Lithium Carbonate: Clinical Trials

30 trials of Lithium Carbonate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 4 terminated, 3 recruiting, 2 unknown. 30 Phase 2, 7 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 230Completed 20, Terminated 4, Recruiting 3, Unknown 2, Withdrawn 1
Phase 17Completed 5, Recruiting 2
Phase 34Completed 2, Recruiting 1, Terminated 1

Follow Lithium Carbonate: new trials by email Literature Review of Lithium Carbonate trials Research Report on Lithium Carbonate

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
AL001, Lithium carbonate - Bipolar I Disorder
Phase 1 / Phase 2RecruitingAlzamend Neuro, Inc.202026-05-112026-07-28
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment
Lithium Carbonate Capsule - Cornelia De Lange Syndrome
Phase 2 / Phase 3RecruitingUniversity of Milan342024-05-012025-01-28
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Fluoxetine, Sertraline, Vortioxetine - Depression, Sequestra
Phase 1 / Phase 2RecruitingFirst Affiliated Hospital of Chongqing Medical University5202023-02-202026-01-27
The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis
Lithium Carbonate - Familial Adenomatous Polyposis
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)122022-06-022024-10-04
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Lithium, Placebo, Ketamine - Treatment Resistant Depression
Phase 2WithdrawnWilliam V. Bobo, M.D.2017-11-302018-08-16
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
Lithium Carbonate, Lactose Placebo - Fractures
Phase 2UnknownSunnybrook Health Sciences Centre1602017-07-212024-01-26
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
Lithium Carbonate, Placebo - Frontotemporal Dementia (FTD)
Phase 2CompletedColumbia University172017-01-272025-02-03
Treatment of Psychosis and Agitation in Alzheimer's Disease
Lithium, Placebo - Alzheimer's Disease, Psychosis
Phase 2CompletedNew York State Psychiatric Institute772014-06-012024-05-02
Ketamine Plus Lithium in Treatment-Resistant Depression
Lithium, Ketamine, Placebo - Depression
Phase 2CompletedIcahn School of Medicine at Mount Sinai342013-07-012018-07-31
Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain
Lithium Carbonate, Placebo - Neuropathic Pain, Neuralgia
Phase 2CompletedChina Spinal Cord Injury Network602013-05-012016-01-28
Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain
Lithium Carbonate, Prophylactic cranial irradiation - Small Cell Lung Carcinoma
Phase 1 / Phase 2CompletedWashington University School of Medicine192012-04-262018-07-05
Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury
Umbilical Cord Blood Mononuclear Cell, Methylprednisolone, Lithium Carbonate Tablet - Spinal Cord Injuries
Phase 1 / Phase 2CompletedChina Spinal Cord Injury Network202011-09-012014-08-21
Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury
Conventional Treatment, Lithium Carbonate Tablet, Cord Blood Cell - Spinal Cord Injury
Phase 1 / Phase 2CompletedChina Spinal Cord Injury Network162011-09-012014-01-28
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
Lithium Carbonate, Placebo - Spinocerebellar Ataxia Type 3, Machado Joseph Disease
Phase 2 / Phase 3CompletedHospital de Clinicas de Porto Alegre622011-05-012013-01-30
A Pilot Study of Lithium in Progressive Multiple Sclerosis
Lithium Carbonate - Multiple Sclerosis
Phase 1 / Phase 2CompletedVA Office of Research and Development232011-05-012019-09-10
Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania.
Lithium Carbonate, Placebo - Bipolar Disorder
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)812010-06-012013-10-09
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Temozolomide, Bevacizumab, Lithium Carbonate - Brain Cancer
Phase 2TerminatedNYU Langone Health282010-05-012016-08-04
Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
Lithium Carbonate, Placebo, Citalopram - Major Depressive Disorder, Dysthymia
Phase 2CompletedColumbia Northwest Pharmaceuticals802010-03-012011-08-24
Lithium in Multiple System Atrophy
Lithium Carbonate, Placebo - Multiple System Atrophy
Phase 2TerminatedFederico II University102009-10-012014-02-03
Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
LITHIUM CARBONATE - SPINOCEREBELLAR ATAXIA 2
Phase 2CompletedFederico II University202009-10-012013-01-08

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Depression (4)  ·  Spinal Cord Injuries (4)  ·  Bipolar Disorder (3)  ·  Alzheimer Disease (2)  ·  Amyotrophic Lateral Sclerosis (2)  ·  Depressive Disorder, Major (2)  ·  Spinocerebellar Ataxias (2)  ·  Adenomatous Polyposis Coli (1)  ·  Aggression (1)  ·  Borderline Personality Disorder (1)  ·  Brain Neoplasms (1)  ·  Callosities (1)  ·  Carcinoma, Medullary (1)  ·  Cocaine-Related Disorders (1)  ·  Cognitive Dysfunction (1)

Sponsors

China Spinal Cord Injury Network (4)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Federico II University (2)  ·  University of Wisconsin, Madison (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Alzamend Neuro, Inc. (1)  ·  Columbia Northwest Pharmaceuticals (1)  ·  Columbia University (1)  ·  First Affiliated Hospital of Chongqing Medical University (1)  ·  Forbes Norris MDA/ALS Research Center (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Massachusetts General Hospital (1)  ·  NYU Langone Health (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (17)  ·  China (5)  ·  Italy (3)  ·  Brazil (2)  ·  Canada (2)  ·  Australia (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Alessandro Filla, MD (2)  ·  Herbert Chen, MD (2)  ·  Hui Zhu, MD (2)  ·  Adam R Winstock, MBBS BSc MSc MRCP(UK) MRCP (1)  ·  Aglaia Vignoli, Professor, MD (1)  ·  Arifulla Khan, MD (1)  ·  Clifford Robinson, M.D. (1)  ·  DP Devanand, MD (1)  ·  Deborah Gruber, MD (1)  ·  Diane Nam, MSc,MD,FRCSC (1)  ·  Edward Huey, MD (1)  ·  Ihsan M Salloum, MD, MPH (1)  ·  James W Murrough, MD (1)  ·  Jianjun Li, M.D. (1)  ·  Jinsy Andrews, MD (1)

Results publications

PMID 30738555, PMID 18700004, PMID 20363190, PMID 21393344, PMID 21525519, PMID 22105463, PMID 24399647, PMID 25093483, PMID 26297649, PMID 26459650, PMID 29859917, PMID 30947755, PMID 31915160, PMID 32760832, PMID 34059401, PMID 35962368, PMID 37732619, PMID 37794802, PMID 37891522

NIH funding

R01AG047146 (1), R01DA019992 (1), R21CA117117 (1), U01NS049640 (1)